West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$368.18 USD
-17.55 (-4.55%)
Updated Apr 25, 2024 04:02 PM ET
After-Market: $368.10 -0.08 (-0.02%) 5:38 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO4/25/24 |
---|---|
Current Quarter | 1.29 |
EPS Last Quarter | 1.83 |
Last EPS Surprise | 2.81% |
ABR | 1.57 |
Earnings ESP
|
0.81% |
---|---|
Current Year | 7.62 |
Next Year | 9.12 |
EPS (TTM) | 8.08 |
P/E (F1) | 50.63 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 673.40M | 763.24M | 3.01B | 3.28B |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 676.63M | 765.40M | 3.02B | 3.32B |
Low Estimate | 670.90M | 761.95M | 3.01B | 3.26B |
Year ago Sales | 716.60M | 753.80M | 2.95B | 3.01B |
Year over Year Growth Est. | -6.03% | 1.25% | 2.12% | 8.83% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.29 | 2.00 | 7.62 | 9.12 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | 1.30 | 1.97 | 7.55 | 9.01 |
High Estimate | 1.33 | 2.04 | 7.89 | 9.39 |
Low Estimate | 1.23 | 1.97 | 7.50 | 9.00 |
Year ago EPS | 1.98 | 2.11 | 8.08 | 7.62 |
Year over Year Growth Est. | -34.85% | -5.21% | -5.69% | 19.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.29 | 2.00 | 7.62 | 9.12 |
7 Days Ago | 1.29 | 2.00 | 7.62 | 9.12 |
30 Days Ago | 1.31 | 2.00 | 7.63 | 9.12 |
60 Days Ago | 1.44 | 2.07 | 7.95 | 9.20 |
90 Days Ago | 2.14 | 2.33 | 8.77 | 9.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.30 | 1.97 | 7.55 | 9.01 |
Zacks Consensus Estimate | 1.29 | 2.00 | 7.62 | 9.12 |
Earnings ESP | 0.81% | -1.58% | -0.90% | -1.18% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.83 | 2.16 | 2.11 | 1.98 | NA |
Estimate | 1.78 | 1.86 | 1.95 | 1.67 | NA |
Difference | 0.05 | 0.30 | 0.16 | 0.31 | 0.21 |
Surprise | 2.81% | 16.13% | 8.21% | 18.56% | 11.43% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more